MicroRNA-30c-regulated HDAC9 mediates chemoresistance of breast cancer.

Liang Z, Feng A, Shim H

DOI: 10.1007/s00280-019-04024-9
Published: 2020 Feb
Container: Cancer chemotherapy and pharmacology
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00280-019-04024-9,
  title = {MicroRNA-30c-regulated HDAC9 mediates chemoresistance of breast cancer.},
  author = {Liang Z and Feng A and Shim H},
  year = {2020},
  journal = {Cancer chemotherapy and pharmacology},
  doi = {10.1007/s00280-019-04024-9},
  url = {https://doi.org/10.1007/s00280-019-04024-9}
}

RIS

TY  - JOUR
TI  - MicroRNA-30c-regulated HDAC9 mediates chemoresistance of breast cancer.
AU  - Liang Z
AU  - Feng A
AU  - Shim H
PY  - 2020
JO  - Cancer chemotherapy and pharmacology
DO  - 10.1007/s00280-019-04024-9
UR  - https://doi.org/10.1007/s00280-019-04024-9
ER  -

APA

Z, L., A, F., & H, S. (2020). MicroRNA-30c-regulated HDAC9 mediates chemoresistance of breast cancer.. Cancer chemotherapy and pharmacology. https://doi.org/10.1007/s00280-019-04024-9

Source records

pubmed · retrieved 2026-09-24T20:29:10.965Z